| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |